nivaldipine
Small moleculeexperimental
Clinical trial activity
1 trials · 15 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 24, 2013 (NCT02017340)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Voltage-gated calcium channelANTAGONIST
Voltage-gated calcium channel antagonist
- Voltage-dependent T-type calcium channel subunit alpha-1H (CACNA1H) ↗
- Voltage-dependent calcium channel subunit alpha-2/delta-1 (CACNA2D1) ↗
- Voltage-dependent L-type calcium channel subunit alpha-1C (CACNA1C) ↗
- Voltage-dependent calcium channel subunit alpha-2/delta-3 (CACNA2D3) ↗
- Voltage-dependent L-type calcium channel subunit alpha-1S (CACNA1S) ↗
- Voltage-dependent calcium channel subunit alpha-2/delta-2 (CACNA2D2) ↗
- Voltage-dependent L-type calcium channel subunit alpha-1D (CACNA1D) ↗
- Voltage-dependent P/Q-type calcium channel subunit alpha-1A (CACNA1A) ↗
- Voltage-dependent N-type calcium channel subunit alpha-1B (CACNA1B) ↗
- Voltage-dependent T-type calcium channel subunit alpha-1G (CACNA1G) ↗
- Voltage-dependent calcium channel subunit alpha-2/delta-4 (CACNA2D4) ↗
- Voltage-dependent T-type calcium channel subunit alpha-1I (CACNA1I) ↗
- Voltage-dependent L-type calcium channel subunit alpha-1F (CACNA1F) ↗
- Voltage-dependent R-type calcium channel subunit alpha-1E (CACNA1E) ↗
- Voltage-dependent L-type calcium channel subunit beta-3 (CACNB3) ↗
- Voltage-dependent calcium channel gamma-7 subunit (CACNG7) ↗
- Voltage-dependent calcium channel gamma-5 subunit (CACNG5) ↗
- Voltage-dependent calcium channel gamma-2 subunit (CACNG2) ↗
- Voltage-dependent L-type calcium channel subunit beta-4 (CACNB4) ↗
- Voltage-dependent L-type calcium channel subunit beta-2 (CACNB2) ↗
- Voltage-dependent L-type calcium channel subunit beta-1 (CACNB1) ↗
- Voltage-dependent calcium channel gamma-4 subunit (CACNG4) ↗
- Voltage-dependent calcium channel gamma-8 subunit (CACNG8) ↗
- Voltage-dependent calcium channel gamma-3 subunit (CACNG3) ↗
- Voltage-dependent calcium channel gamma-6 subunit (CACNG6) ↗
- Voltage-dependent calcium channel gamma-1 subunit (CACNG1) ↗
- Voltage-gated T-type calcium channel alpha-1H subunit
- Voltage-gated calcium channel alpha2/delta subunit 1
- Voltage-gated L-type calcium channel alpha-1C subunit
- Voltage-gated N-type calcium channel alpha-1B subunit
- Voltage-gated L-type calcium channel alpha-1S subunit
- Voltage-gated L-type calcium channel alpha-1D subunit
- Voltage-gated calcium channel alpha2/delta subunit 2
- Voltage-gated P/Q-type calcium channel alpha-1A subunit
- Voltage-gated T-type calcium channel alpha-1G subunit
- Voltage-gated T-type calcium channel alpha-1I subunit
- Voltage-dependent R-type calcium channel subunit alpha-1E
- Voltage-gated L-type calcium channel
- Voltage-gated T-type calcium channel
- Voltage-dependent L-type calcium channel subunit beta-2
- Voltage-dependent N-type calcium channel subunit alpha-1B/Voltage-dependent calcium channel subunit alpha-2/delta-1/Voltage-dependent L-type calcium channel subunit beta-3
- Voltage-dependent L-type calcium channel alpha1C/alpha2delta/beta1b
- Voltage-dependent P/Q-type calcium channel alpha1A/alpha2delta/beta1b
- N-type calcium channel alpha-1b/alpha2delta-1/beta-1b
- L-type calcium channel alpha-1c/beta-2/alpha2delta-1
- Voltage-dependent L-type calcium channel subunit beta-3
- Voltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-3/calcium channel subunit alpha-2/delta-1
Voltage-gated L-type calcium channel blocker
Chemistry & pharmacology
Loading structure…
SMILES
COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1- Mol. weight
- 385.38 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL517427 ↗
Also known as
- 3,5-pyridinedicarboxylic acid, 2-cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-methyl 5-(1-methylethyl) ester
- 5-isopropyl-3-methyl-2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinecarboxylate
- cl-287389
- cl-287389
- dolorgiet brand of nilvadipine
- escor
- fk-235
- fk-235
- fr 34235
- fr-34235
- fr-34235
- fr-34235
- fr-34235
- fr-34235
- fr-34235
- klinge brand of nilvadipine
- nilvadipine
- nilvadipine
- nilvadipine
- nilvadipine
- nilvadipine
- nilvadipine
- nilvadipine
- nivadil
- nivadil
- nivadil
- nivadil
- nivadipine
- nivadipine
- nivaldipine
- sk&f-102362
- sk&f-102362
- trommsdorff brand of nilvadipine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02017340 | Phase 3 | Apr 24, 2013 | Alzheimer Europe, Archer Pharmaceuticals, Inc., Aristotle University of Thessaloniki, E-Search Limited, Goeteborgs Universitet, Katholieke Universiteit Leuven, Mario Negri Institute, Molecular Medicine Ireland LBG, National University of Ireland, St. James's Hospital, Ireland, Szeged University, Trinity College Dublin, University of Lille, University of London, University of Ulm |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alzheimer Europe | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Archer Pharmaceuticals, Inc. | For profit | 1 | 0 | 1 | 2013 |
| Aristotle University of Thessaloniki | Academic/Hospital | 1 | 0 | 1 | 2013 |
| E-Search Limited | For profit | 1 | 0 | 1 | 2013 |
| Goeteborgs Universitet | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Mario Negri Institute | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Molecular Medicine Ireland LBG | Academic/Hospital | 1 | 0 | 1 | 2013 |
| National University of Ireland | Academic/Hospital | 1 | 0 | 1 | 2013 |
| St. James's Hospital, Ireland | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Szeged University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Trinity College Dublin | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Lille | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Ulm | Academic/Hospital | 1 | 0 | 1 | 2013 |
15 organizations
Page 1 / 1